Severe acute hepatitis after resumption of interferon-beta therapy for multiple sclerosis: A word of caution [6]

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2606-2607

  Grieco, Antonio ^a   Montalto, Massimo ^a   Vero, Vittoria ^a   Vecchio, Fabio Maria ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BETA INTERFERON; BETA1A INTERFERON; METHYLPREDNISOLONE; URSODEOXYCHOLIC ACID;

ACUTE HEPATITIS; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LABORATORY TEST; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MEDICAL EXAMINATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUTE DISEASE; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS, TOXIC; HUMANS; INTERFERON-BETA; LIVER FUNCTION TESTS; MULTIPLE SCLEROSIS;

EID: 35448995114     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01514_6.x     Document Type: Letter

References (5)

1. Tremlett HL, Yoshida EM, Oger J. Liver injury associated with the beta-interferons for MS: A comparison between the three products. Neurology 2004 62 : 628 31.
2. Walther EU, Hohlfeld R. Multiple sclerosis: Side effects of interferon beta therapy and their management. Neurology 1999 53 : 1622 7.
3. Francis GS, Grumser Y, Alteri E, et al. Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: Incidence and clinical significance. Drug Saf 2003 26 : 815 27.
4. Durelli L, Ferrero B, Oggero A, et al. Betaferon Safety Trial (BEST) Study Group. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS. Neurology 2001 57 : 1363 70.
5. Yoshida EM, Rasmussen SL, Steinbrecher UP, et al. Fulminant liver failure during interferon beta treatment of multiple sclerosis. Neurology 2001 56 : 1416.